The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in ...

Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal ...

Macular degeneration is a leading cause of vision loss, especially in people over the age of 50. It affects the macula, a ...

Abnormalities of the vitreoretinal interface may contribute to important retinal pathologies such as diabetic retinopathy, diabetic macular edema and age-related macular degeneration. The ...

Updates CES 2025, the Consumer Electronics Show, is just a few hours away! Scheduled from January 7 to January 10, 2025, this ...

Indeed, many myths about cancer are still around and, unfortunately, some people still believe them. Cancer has claimed many ...

The beginning of the new CPD cycle means it is time to prepare a new professional development plan (PDP) and sketch out areas ...

REED CITY — It has been one year since Riemer Eye Center purchased Precision ICare in Reed City. With the growth of the ...

When it comes to maintaining optimal health, our blood plays a crucial role. It acts as the body’s transportation system, ...

SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.